UKRP, Importer and Distributor: Roles, Notification Duties and Northern Ireland Rules

1. Key takeaways

The three economic operator roles in the United Kingdom divide cleanly. The UKRP is appointed by an overseas manufacturer, assumes statutory duties and handles MHRA registration. The importer has a place of business in Great Britain and its duty is to inform the relevant manufacturer or UKRP of its intention to import; the manufacturer or the UKRP then submits the importer’s details, including its place of business in Great Britain, to MHRA. Pure distributors and other suppliers who do not import devices do not need to register with MHRA. The law does not prohibit an importer or distributor from also acting as the UKRP. For market-entry planning, the practical consequence is that the most important contract question is not who sells the device but who physically causes it to enter Great Britain, because that decision determines who must be registered, who must notify whom, and who answers to MHRA for the import step. This article separates the three roles, explains the notification-based importer mechanism, the importer’s marking-check duty, and the distinct Northern Ireland rules.

2. Legal basis

• UK MDR 2002 (SI 2002/618, as amended): reg 60 (status of the UKRP); Part VII reg 59–67.
• Official guidance: GOV.UK, Regulating medical devices in the UK (the UK responsible person, and Importers and distributors, sections) and GOV.UK, Register medical devices to place on the market (the Registration of importers section).

Part VII of the UK MDR 2002, covering regulations 59 to 67, is the backbone of the economic operator framework: it defines the obligations that apply at each stage of the supply chain and gives MHRA its enforcement tools. Reg 60 sits within that Part and establishes the UKRP, which is why the UKRP can be described as an economic operator with statutory standing rather than a contractual service provider only. The official guidance documents translate these provisions into operational terms: the Regulating medical devices in the UK guidance describes who the UKRP, importers and distributors are and what each must do, while the Register medical devices to place on the market guidance explains how importer details reach the registration system and whose responsibility the submission is. Reading the two together is essential, because the registration mechanics and the substantive duties live in different documents.

3. Expert insights

Insight 1: the importer’s duty is to notify, and the submission responsibility sits with the manufacturer or the UKRP. The official guidance is explicit: where an importer based in Great Britain is not also the UKRP, the importer must inform the relevant manufacturer or UKRP of its intention to import. At that point it is the manufacturer or the manufacturer’s UKRP that is responsible for submitting the importer’s details to MHRA, including the importer’s place of business in Great Britain. This allocation of responsibility determines who should maintain the importer’s data in DORS. Many compliance programmes get this backwards, treating importer registration as the importer’s own task; in fact the importer triggers the process, but the manufacturer or UKRP performs it, and any gap between notification and submission is a compliance gap attributable to the manufacturer side.

Insight 2: importers also have a substantive duty to check the marking. The official guidance notes that importers are additionally subject to obligations covering the storage and transport of devices, and the checking of devices for the CE or UKCA marking. This is an enforceable checkpoint at the import stage: an importer receiving goods that bear neither mark, or goods whose marking does not match the accompanying documentation, is not a neutral warehouse but a regulated operator holding non-conforming stock. Commercial partners should be told at onboarding that the importer role carries these checks, so that marking discrepancies are raised before goods move further down the supply chain rather than discovered during an inspection.

Insight 3: Northern Ireland importers follow the EU rules. The official guidance states that importers in Northern Ireland must comply with the importer obligations under the EU MDR (2017/745) or EU IVDR (2017/746); and that from 28 May 2026, importers in Northern Ireland must complete registration in EUDAMED. This means a company importing into both Great Britain and Northern Ireland operates under two importer regimes simultaneously, with different verification duties and a separate registration step for the Northern Ireland flow. Logistics teams and compliance teams need to be able to tell, for any given shipment, which side of the border the importer obligations attach to, and the answer is not always obvious for goods moving between Great Britain and Northern Ireland.

4. Practical recommendations

GRZAN recommends making who is the importer explicit in commercial agreements. If the UKRP also performs the import function, no separate submission is needed. If a third-party importer is used, the notification and the DORS submission must be completed before the import takes place, to avoid creating the compliance gap of goods that have been imported but not reported. Draft the import clause to cover notification timing, the data set to be provided (legal name, place of business in Great Britain, contact details), and confirmation that the submission to MHRA has been made. In addition, establish a quarterly review of the importer list: importers change with distribution strategy, warehouses move, and new channels such as marketplaces can create importer roles that no one has notified. A short quarterly review keeps the registration record aligned with the physical supply chain and gives early warning of submissions that need to be made.

5. Verification checklist

Before the first shipment, confirm each of the following items.

• □ The identities of the UKRP, importer and distributor have each been defined
• □ The importer has notified the manufacturer/UKRP of its intention to import
• □ The importer’s details have been submitted to MHRA by the manufacturer/UKRP
• □ It has been confirmed whether the distributor triggers importer obligations
• □ Importers in Northern Ireland have been handled under the EU MDR/IVDR and EUDAMED requirements

Regulatory information verified as of 29 October 2026.

• Appointment of the UK responsible person (UKRP) and support for signing the letter of designation
• End-to-end MHRA registration (DORS) filing and account lifecycle management
• Device classification assessment, GMDN code selection and annual registration fee calculation
• Dual-pathway design for Great Britain and Northern Ireland, including the UK(NI) option
• Post-market surveillance (PMS) system setup, PMSR/PSUR preparation and vigilance report submission
• Emergency handling of serious adverse events and field safety corrective actions (FSCA)
• Monitoring of UK regulatory changes and compliance gap assessment

Working with GRZAN. GRZAN Global supports manufacturers entering the United Kingdom market with the full scope of UKRP and fee-budgeting services described above: appointing and documenting the UK responsible person (UKRP), mapping importer and distributor obligations onto your commercial agreements, managing MHRA DORS registration and account lifecycles, and forecasting annual registration fees by GMDN category. For a consultation on your supply chain roles and registration duties, contact us at info@grzanglobal.com.